Stocks · News reference

OrganiGram Holdings Q3 Sales $76.413M Beat $67.660M Estimate

2026-08-11 10:07:47 UTCBenzinga Newsdesk

OrganiGram Holdings (NASDAQ:OGI) reported quarterly sales of $76.413 million which beat the analyst consensus estimate of $67.660 million by 12.94 percent. This is a 49.41 percent increase over sales of $51.142 million

More stocks news Connected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

OGI

Source: benzinga
Observed: 2026-08-11 10:07:47 UTC
Checked: 2026-08-11 10:07:50 UTC
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

The Motley Fool2026-11-09 18:50:02 UTCDavid Jagielski, Cpa
The Big Winner From the Aurora Cannabis-Organigram Deal: Curaleaf
Organigram agreed to acquire Aurora Cannabis at a 21% premium over Curaleaf's hostile takeover offer. However, the article argues that Curaleaf emerges as the real winner because the combined Organigram-Aurora entity will be more entrenched in the declining Canadian recreational cannabis market. Curaleaf, with stronger financials and U.S. operations, may eventually acquire the combined company at a lower valuation if the deal underperforms.
ACB OGI
Fiscal.ai2026-11-04 14:03:34 UTC
Organigram Global Inc. to Acquire Aurora Cannabis Inc. for C$561 Million
Organigram Global Inc. has entered into an arrangement agreement to acquire all issued and outstanding common shares of Aurora Cannabis Inc. for C$7.80 per share.
OGI
Benzinga2026-11-03 14:19:48 UTCBenzinga News-desk
Organigram To Acquire Aurora Cannabis For C$561 Million, Or C$7.80 Per Share
ACB OGI TSX:ACB TSX:OGI
Fiscal.ai2026-11-03 14:03:43 UTC
Canadian Investment Regulatory Organization Implements Trading Halt on Organigram Global Inc.
The Canadian Investment Regulatory Organization (CIRO) issued a temporary trading halt for Organigram Global Inc. (TSX: OGI) on November 3, 2026, pending the release of news.
OGI
Benzinga2026-10-15 10:12:48 UTCBenzinga Newsdesk
Organigram Global Issues Update On Integration Of Sanity Group; Expects To Deliver FY27 Annualized Run-Rate Cost Savings Of $8M-$10M
HighlightsAnnualized savings: expected to be in the range of $8 million to $10 million, comprising approximately $4.5 million to $5.5 million in selling, general and administrative ("SG&A") expenses and
OGI
Benzinga2026-09-30 15:44:52 UTCBenzinga Newsdesk
Shares of cannabis-related companies are trading lower following a report suggesting that a Drug Enforcement Administration judge is pausing proceedings in an ongoing hearing on the Trump administration’s marijuana rescheduling proposal.
ACB CNBS IMCC MJ MSOS

OrganiGram Holdings Q3 Sales $76.413M Beat $67.660M Estimate

Connected Markets

Related Headlines

The Big Winner From the Aurora Cannabis-Organigram Deal: Curaleaf

Organigram Global Inc. to Acquire Aurora Cannabis Inc. for C$561 Million

Organigram To Acquire Aurora Cannabis For C$561 Million, Or C$7.80 Per Share

Canadian Investment Regulatory Organization Implements Trading Halt on Organigram Global Inc.

Organigram Global Issues Update On Integration Of Sanity Group; Expects To Deliver FY27 Annualized Run-Rate Cost Savings Of $8M-$10M

Shares of cannabis-related companies are trading lower following a report suggesting that a Drug Enforcement Administration judge is pausing proceedings in an ongoing hearing on the Trump administration’s marijuana rescheduling proposal.